Grant Publications
Proposal No. IBD-0123
Principal Investigator: Pieter Rottiers, Ph.D. (replacement PI); Claude Cuvelier, M.D., Ph.D. (original PI)
Current Applicant Organization: Flanders Interuniversity Institute for Biotechnology vzw (Ghent, Belgium)
Original Applicant Organization: Ghent University (Belgium)
Project Title: Treatment of experimental colitis by camelid antibody fragments: local delivery by genetically engineered lactococci administration and evaluation of their therapeutic potential
Period of Award: July 1, 2004 - June 30, 2006
Vanderbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P. Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology 2010;3:49-56.
Principal Investigator: Pieter Rottiers, Ph.D. (replacement PI); Claude Cuvelier, M.D., Ph.D. (original PI)
Current Applicant Organization: Flanders Interuniversity Institute for Biotechnology vzw (Ghent, Belgium)
Original Applicant Organization: Ghent University (Belgium)
Project Title: Treatment of experimental colitis by camelid antibody fragments: local delivery by genetically engineered lactococci administration and evaluation of their therapeutic potential
Period of Award: July 1, 2004 - June 30, 2006
Vanderbroucke K, de Haard H, Beirnaert E, Dreier T, Lauwereys M, Huyck L, Van Huysse J, Demetter P, Steidler L, Remaut E, Cuvelier C, Rottiers P. Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology 2010;3:49-56.